COR Therapeutics Inc
San Francisco
About COR Therapeutics Inc
COR Therapeutics is engaged in the discovery, development, and marketing of novel therapeutic products for treating and preventing acute and chronic cardiovascular diseases. The company’s product portfolio includes Integrilin Injection which is used to treat individuals with cardiovascular diseases. COR Therapeutics also has several product development programs underway to address unmet clinical needs in the management of patients suffering from disorders such as unstable angina, coronary angioplasty, acute myocardial infarction, stroke, and deep vein thrombosis. COR Therapeutics was founded by Lee Douglas and Lewis T. ""Rusty"" Williams in San Francisco, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
Canonical: https://fsome.com/organization/cor-therapeutics-inc-2622453 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.